Yahoo · Oct 23, 2026
How Global Drug Expansion At Fosun International (SEHK:656) Has Changed Its Investment Story
At the Sustainability Global Leaders Conference 2026, Fosun International Co-CEO Chen Qiyu outlined how Fosun Pharma is pushing Chinese drugs such as HANQUYOU into major overseas markets while stressing affordability, quality and wider patient access. The emphasis on original drug development, AI supported R&D and broader reach in emerging markets signals management attention on healthcare as a long term growth pillar within Fosun International’s diversified portfolio. We will examine how...

